Identification of genetic variation in 11 candidate genes of canine mammary tumour

Veterinary and Comparative Oncology

Volumn 9, Issue 4, 2011, Pages 241-250

  Borge, K S ^a   Borresen Dale A L ^b,c   Lingaas, F ^a  

^a NORWEGIAN UNIVERSITY OF LIFE SCIENCES   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

Dog; Mammary tumour; Risk allele; Sequencing; Single nucleotide polymorphism

Indexed keywords

PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

ANIMAL; ANIMAL DISEASE; ARTICLE; DOG; DOG DISEASE; EXPERIMENTAL NEOPLASM; FEMALE; GENETIC VARIABILITY; GENETICS; NORWAY; NUCLEIC ACID DATABASE; POLYMERASE CHAIN REACTION; PROTO ONCOGENE; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR SUPPRESSOR GENE;

ANIMALS; DATABASES, NUCLEIC ACID; DOG DISEASES; DOGS; FEMALE; GENES, BRCA1; GENES, BRCA2; GENES, ERBB-1; GENES, ERBB-2; GENES, P53; GENETIC VARIATION; MAMMARY NEOPLASMS, ANIMAL; NORWAY; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PTEN PHOSPHOHYDROLASE; SEQUENCE ANALYSIS;

CANIS FAMILIARIS;

EID: 80755169259     PISSN: 14765810     EISSN: 14765829     Source Type: Journal    
DOI: 10.1111/j.1476-5829.2010.00250.x     Document Type: Article

References (52)

1. Arnesen K, Gamlem H, Glattre E, Grøndalem J, Moe L and Nordstoga K. The Norwegian canine cancer register 1990-1998. Report from the project "Cancer in the dog". European Journal of Companion Animal Practice 2001; 11: 159-169.
2. Boldizsar H, Szenci O, Muray T and Csenki J. Studies on canine mammary tumours. I. Age, seasonal and breed distribution. Acta Veterinaria Hungarica 1992; 40: 75-87.
3. Egenvall A, Bonnett BN, Ohagen P, Olson P, Hedhammar A and von Euler H. Incidence of and survival after mammary tumors in a population of over 80, 000 insured female dogs in Sweden from 1995 to 2002. Preventive Veterinary Medicine 2005; 69: 109-127.
4. Moe L. Population-based incidence of mammary tumours in some dog breeds. Journal of Reproduction and Fertility Supplement 2001; 57: 439-443.
5. Dahl K, Moe L, Indrebø I and Gamlem H. Forekomst av mammatumor hos beslektede boxere [Occurence of mammary tumor in related Boxers]. Norsk Veterinærtidsskrift 2002; 114: 615-622.
6. Rivera P, Melin M, Biagi T, Fall T, Haggstrom J, Lindblad-Toh K and von Euler H. Mammary tumor development in dogs is associated with BRCA1 and BRCA2. Cancer Research 2009; 69: 8770-8774.
7. Priester WA. Occurrence of mammary neoplasms in bitches in relation to breed, age, tumour type, and geographical region from which reported. The Journal of Small Animal Practice 1979; 20: 1-11.
8. Patterson DF. Companion animal medicine in the age of medical genetics. Journal of Veterinary Internal Medicine 2000; 14: 1-9.
9. Ostrander EA and Wayne RK. The canine genome. Genome Research 2005; 15: 1706-1716.
10. Martin AM and Weber BL. Genetic and hormonal risk factors in breast cancer. Journal of the National Cancer Institute 2000; 92: 1126-1135.
11. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM and Ding W. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994; 266: 66-71.
12. Wooster R, Neuhausen SL, Mangion J, Quirk Y, Ford D, Collins N, Nguyen K, Seal S, Tran T and Averill D. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 1994; 265: 2088-2090.
13. Vahteristo P, Bartkova J, Eerola H, Syrjakoski K, Ojala S, Kilpivaara O, Tamminen A, Kononen J, Aittomaki K, Heikkila P, Holli K, Blomqvist C, Bartek J, Kallioniemi OP and Nevanlinna H. A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer. American Journal of Human Genetics 2002; 71: 432-438.
14. Thompson D, Duedal S, Kirner J, McGuffog L, Last J, Reiman A, Byrd P, Taylor M and Easton DF. Cancer risks and mortality in heterozygous ATM mutation carriers. Journal of the National Cancer Institute 2005; 97: 813-822.
15. Walsh T and King MC. Ten genes for inherited breast cancer. Cancer Cell 2007; 11: 103-105.
16. Seal S, Thompson D, Renwick A, Elliott A, Kelly P, Barfoot R, Chagtai T, Jayatilake H, Ahmed M, Spanova K, North B, McGuffog L, Evans DG, Eccles D, Easton DF, Stratton MR and Rahman N. Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles. Nature Genetics 2006; 38: 1239-1241.
17. Peto J, Collins N, Barfoot R, Seal S, Warren W, Rahman N, Easton DF, Evans C, Deacon J and Stratton MR. Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. Journal of the National Cancer Institute 1999; 91: 943-949.
18. Nichols KE, Malkin D, Garber JE, Fraumeni JF Jr and Li FP. Germ-line p53 mutations predispose to a wide spectrum of early-onset cancers. Cancer Epidemiology, Biomarkers & Prevention 2001; 10: 83-87.
19. Szabo CI and King MC. Inherited breast and ovarian cancer. Human Molecular Genetics 1995; 4: 1811-1817.
20. Hopper JL, Southey MC, Dite GS, Jolley DJ, Giles GG, McCredie MR, Easton DF and Venter DJ. Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2. Australian Breast Cancer Family Study. Cancer Epidemiology, Biomarkers & Prevention 1999; 8: 741-747.
21. Breast Cancer Information Core (2010) [accessed 20 September 2010].
22. Lynch ED, Ostermeyer EA, Lee MK, Arena JF, Ji H, Dann J, Swisshelm K, Suchard D, MacLeod PM, Kvinnsland S, Gjertsen BT, Heimdal K, Lubs H, Moller P and King MC. Inherited mutations in PTEN that are associated with breast cancer, cowden disease, and juvenile polyposis. American Journal of Human Genetics 1997; 61: 1254-1260.
23. Rhei E, Kang L, Bogomolniy F, Federici MG, Borgen PI and Boyd J. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas. Cancer Research 1997; 57: 3657-3659.
24. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A and McGuire WL. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987; 235: 177-182.
25. Anderson TI, Wooster R, Laake K, Collins N, Warren W, Skrede M, Elles R, Tveit KM, Johnston SR, Dowsett M, Olsen AO, Moller P, Stratton MR and Borresen-Dale AL. Screening for ESR mutations in breast and ovarian cancer patients. Human Mutation 1997; 9: 531-536.
26. Weber F, Fukino K, Sawada T, Williams N, Sweet K, Brena RM, Plass C, Caldes T, Mutter GL, Villalona-Calero MA and Eng C. Variability in organ-specific EGFR mutational spectra in tumour epithelium and stroma may be the biological basis for differential responses to tyrosine kinase inhibitors. British Journal of Cancer 2005; 92: 1922-1926.
27. Masciari S, Larsson N, Senz J, Boyd N, Kaurah P, Kandel MJ, Harris LN, Pinheiro HC, Troussard A, Miron P, Tung N, Oliveira C, Collins L, Schnitt S, Garber JE and Huntsman D. Germline E-cadherin mutations in familial lobular breast cancer. Journal of Medical Genetics 2007; 44: 726-731.
28. Hemminki A, Markie D, Tomlinson I, Avizienyte E, Roth S, Loukola A, Bignell G, Warren W, Aminoff M, Hoglund P, Jarvinen H, Kristo P, Pelin K, Ridanpaa M, Salovaara R, Toro T, Bodmer W, Olschwang S, Olsen AS and Stratton MR, de la CA and Aaltonen LA.A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature 1998; 391: 184-187.
29. Nieto A and Perez-Alenza MD, del CN, Tabanera E, Castano M and Pena L. BRCA1 expression in canine mammary dysplasias and tumours: relationship with prognostic variables. Journal of Comparative Pathology 2003; 128: 260-268.
30. Kanae Y, Endoh D, Yokota H, Taniyama H and Hayashi M. Expression of the PTEN tumor suppressor gene in malignant mammary gland tumors of dogs. American Journal of Veterinary Research 2006; 67: 127-133.
31. Veldhoen N, Watterson J, Brash M and Milner J. Identification of tumour-associated and germ line p53 mutations in canine mammary cancer. British Journal of Cancer 1999; 81: 409-415.
32. Lee CH, Kim WH, Lim JH, Kang MS, Kim DY and Kweon OK. Mutation and overexpression of p53 as a prognostic factor in canine mammary tumors. Journal of Veterinary Science 2004; 5: 63-69.
33. Sarli G, Preziosi R, De TL, Brunetti B and Benazzi C. E-cadherin immunoreactivity in canine mammary tumors. Journal of Veterinary Diagnostic Investigation 2004; 16: 542-547.
34. Torres LN, Matera JM, Vasconcellos CH, Avanzo JL, Hernandez-Blazquez FJ and Dagli ML. Expression of connexins 26 and 43 in canine hyperplastic and neoplastic mammary glands. Veterinary Pathology 2005; 42: 633-641.
35. Matsuyama S, Nakamura M, Yonezawa K, Shimada T, Ohashi F, Takamori Y and Kubo K. Expression patterns of the erbB subfamily mRNA in canine benign and malignant mammary tumors. The Journal of Veterinary Medical Science 2001; 63: 949-954.
36. Ensembl release 57 (2010) [accessed 1 March 2010].
37. Rozen S and Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods in Molecular Biology 2000; 132: 365-386.
38. Primer 3 (2009) [accessed 20 September 2010].
39. Bork Group and Sunyaev Lab. PolyPhen: prediction of functional effects of human nsSNPs (2010) [accessed 20 September 2010].
40. USCS Genome Bioinformatics (2010) [accessed 20 September 2010].
41. Nelson DL and Cox MM. Amino acids and peptides. In: Principles of Biochemistry, AL Lehninger, DL Nelson and MM Cox, eds., New York, Worth Publishers, 1993: 111-133.
42. NCBI HomoloGene Release 64 (2009) [accessed 20 September 2010].
43. Vage J and Lingaas F. Single nucleotide polymorphisms (SNPs) in coding regions of canine dopamine- and serotonin-related genes. BMC Genetics 2008; 9: 10.
44. Brouillette JA, Andrew JR and Venta PJ. Estimate of nucleotide diversity in dogs with a pool-and-sequence method. Mammalian Genome 2000; 11: 1079-1086.
45. Shaw SH, Carrasquillo MM, Kashuk C, Puffenberger EG and Chakravarti A. Allele frequency distributions in pooled DNA samples: applications to mapping complex disease genes. Genome Research 1998; 8: 111-123.
46. Le Hellard S, Ballereau SJ, Visscher PM, Torrance HS, Pinson J, Morris SW, Thomson ML, Semple CA, Muir WJ, Blackwood DH, Porteous DJ and Evans KL. SNP genotyping on pooled DNAs: comparison of genotyping technologies and a semi automated method for data storage and analysis. Nucleic Acids Research 2002; 30: e74.
47. Hsu WL, Huang YH, Chang TJ, Wong ML and Chang SC. Single nucleotide variation in exon 11 of canine BRCA2 in healthy and cancerous mammary tissue. Veterinary Journal 2010; 184: 351-356.
48. Thompson D and Easton D. Variation in BRCA1 cancer risks by mutation position. Cancer Epidemiology, Biomarkers & Prevention 2002; 11: 329-336.
49. Berx G, Cleton-Jansen AM, Nollet F and De Leeuw WJ, Van de Vijver MJ, Cornelisse C, van Roy F. E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers. The EMBO Journal 1995; 14: 6107-6115.
50. De Vivo I, Gertig DM, Nagase S, Hankinson SE, O'Brien R, Speizer FE, Parsons R and Hunter DJ. Novel germline mutations in the PTEN tumour suppressor gene found in women with multiple cancers. Journal of Medical Genetics 2000; 37: 336-341.
51. Yoshikawa Y, Morimatsu M, Ochiai K, Nagano M, Yamane Y, Tomizawa N, Sasaki N and Hashizume K. Insertion/deletion polymorphism in the BRCA2 nuclear localization signal. Biomed Research 2005; 26: 109-116.
52. Yoshikawa Y, Morimatsu M, Ochiai K, Nagano M, Yamane Y, Tomizawa N, Sasaki N and Hashizume K. Analysis of genetic variations in the exon 27 region of the canine BRCA2 locus. The Journal of Veterinary Medical Science 2005; 67: 1013-1017.